Form 4: HCA Healthcare Director Andrea B. Smith Reports Acquisition of Common Stock
SEC Form 4 Filing
Director Andrea B. Smith reports the acquisition of 610 shares of HCA Healthcare common stock and indirect ownership of 82 shares through managed accounts.
Summary
- On April 29, 2024, Andrea B. Smith, a director of HCA Healthcare, Inc., acquired 610 shares of common stock as part of an annual director equity award.
- These shares were acquired at a price of $0.00.
- Following the transaction, Smith directly owns 3,512 shares of HCA Healthcare common stock.
- Smith also indirectly owns 82 shares through managed accounts over which she disclaims investment authority.
- A Power of Attorney document is included, appointing John M. Franck II, Natalie Harrison Cline, and Kevin A. Ball as attorneys-in-fact for SEC filings.
Sentiment
Score: 6
Explanation: The document is a standard SEC filing related to stock ownership by a company director. It doesn't contain any information that would significantly impact investor sentiment positively or negatively. The sentiment is neutral.
Positives
- The acquisition of shares by a director can be seen as a positive signal, indicating confidence in the company's future performance.
Future Outlook
The restricted share units will vest on the sooner of the date of the Issuer's 2025 annual shareholders' meeting or the first anniversary of the grant date, and vested shares will be delivered when the reporting person ceases to be a member of the Board of Directors of the Issuer.
Industry Context
This filing is a routine disclosure related to insider transactions, which are common in publicly traded companies. It provides transparency regarding the ownership of company stock by its directors.
Comparison to Industry Standards
- Form 4 filings are standard practice for publicly traded companies like HCA Healthcare, similar to filings made by directors and officers at companies like UnitedHealth Group (UNH) and Tenet Healthcare (THC).
- The reporting requirements are consistent across the healthcare industry to ensure transparency in insider trading activities.
Stakeholder Impact
- The transaction has a minimal direct impact on stakeholders, as it is a routine disclosure of stock ownership by a director.
- It provides transparency to shareholders regarding insider transactions.
Key Dates
| Date | Description |
|---|---|
| 2022-01-24 | Date of Power of Attorney execution. |
| 2024-04-29 | Date of transaction: Andrea B. Smith acquired common stock. |
| 2024-05-01 | Date of signature for the Form 4 filing. |
| 2025 | Vesting date of restricted share units, either at the annual shareholders' meeting or the first anniversary of the grant date. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.